Learn / CYTK
NASDAQ: CYTK
Cytokinetics (CYTK) stock, explained like you're 5
Cytokinetics trades on the Nasdaq under the ticker CYTK. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 8.7 billion dollars.
- Ticker
- CYTK
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 8.7 billion dollars
Is Cytokinetics a small, medium or large cap company?
No. Cytokinetics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 8.7 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Cytokinetics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CYTK stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Cytokinetics, Incorporated (CYTK) stock price, news, quote and history (Yahoo Finance Singapore)
- William Blair initiates Cytokinetics stock coverage with outperform rating (Investing.com)
- Learn Why The Bull Case For Cytokinetics Stock Could Change Following Phase 3 HCM Data (Simply Wall Street)
- A $1.42M proposed share sale at Cytokinetics (CYTK) draws on Robert Blum’s stock options. (Stock Titan)
- Here's How Much $1000 Invested In Cytokinetics 15 Years Ago Would Be Worth Today (Benzinga)
Follow CYTK in your daily brief
Each trading day at 5 PM ET we post what happened to Cytokinetics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CYTK
Questions about Cytokinetics stock
What does Cytokinetics do?
Cytokinetics trades on the Nasdaq under the ticker CYTK. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 8.7 billion dollars.
What is the ticker symbol for Cytokinetics?
Cytokinetics trades under the ticker CYTK on the Nasdaq.
What is Cytokinetics's market cap?
Cytokinetics is a mid cap stock with a market cap of about 8.7 billion dollars.
How does Cytokinetics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CYTK stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CYTK stock every day?
Add CYTK to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.